Pollard S - Search Results

1

Cyclosporine pharmacokinetics and blood pressure responses after conversion to once-daily dosing in maintenance liver transplant patients.

Kovarik JM, Villamil F, Otero A, Levy G, Lynch S, Cillo U, Fischer L, Nashan B, Pollard S, De Carlis L. Kovarik JM, et al. Among authors: pollard s. Clin Transplant. 2008 Jan-Feb;22(1):68-75. doi: 10.1111/j.1399-0012.2007.00747.x. Clin Transplant. 2008. PMID: 18217908 Clinical Trial.

2

Improved clinical outcomes for liver transplant recipients using cyclosporine monitoring based on 2-hr post-dose levels (C2).

Levy G, Burra P, Cavallari A, Duvoux C, Lake J, Mayer AD, Mies S, Pollard SG, Varo E, Villamil F, Johnston A. Levy G, et al. Among authors: pollard sg. Transplantation. 2002 Mar 27;73(6):953-9. doi: 10.1097/00007890-200203270-00022. Transplantation. 2002. PMID: 11923699 Clinical Trial.

3

Potential clinical implications of substitution of generic cyclosporine formulations for cyclosporine microemulsion (Neoral) in transplant recipients.

Johnston A, Belitsky P, Frei U, Horvath J, Hoyer P, Helderman JH, Oellerich M, Pollard S, Riad H, Rigotti P, Keown P, Nashan B. Johnston A, et al. Among authors: pollard s. Eur J Clin Pharmacol. 2004 Aug;60(6):389-95. doi: 10.1007/s00228-004-0774-8. Epub 2004 Jun 17. Eur J Clin Pharmacol. 2004. PMID: 15205865 Review.

4

A pharmacokinetic and clinical review of the potential clinical impact of using different formulations of cyclosporin A. Berlin, Germany, November 19, 2001.

Pollard S, Nashan B, Johnston A, Hoyer P, Belitsky P, Keown P, Helderman H; CONSENT: Consensus on Substitution in European Transplantation. Pollard S, et al. Clin Ther. 2003 Jun;25(6):1654-69. doi: 10.1016/s0149-2918(03)80161-3. Clin Ther. 2003. PMID: 12860490 Review.

5

Comparison of microemulsion and conventional formulations of cyclosporine A in preventing acute rejection in de novo kidney transplant patients. The U.K. Neoral Renal Study Group.

Pollard SG, Lear PA, Ready AR, Moore RH, Johnson RW. Pollard SG, et al. Transplantation. 1999 Nov 15;68(9):1325-31. doi: 10.1097/00007890-199911150-00018. Transplantation. 1999. PMID: 10573071 Clinical Trial.

6

Pharmacologic monitoring and outcomes of cyclosporine.

Pollard SG. Pollard SG. Transplant Proc. 2004 Mar;36(2 Suppl):404S-407S. doi: 10.1016/j.transproceed.2003.12.045. Transplant Proc. 2004. PMID: 15041375 Review.

7

An evaluation of the cyclosporine parent-compound-specific whole blood TDx assay.

Pescovitz MD, Book BK, Pollard SG, Milgrom ML, Leapman SB, Filo RS. Pescovitz MD, et al. Among authors: pollard sg. Clin Transplant. 1992 Feb;6(1):43-7. Clin Transplant. 1992. PMID: 10147649

8

Optimization of cyclosporine therapy in liver transplantation.

Pollard SG, Lodge JP. Pollard SG, et al. Transplant Proc. 1998 Aug;30(5):1816-8. doi: 10.1016/s0041-1345(98)00443-6. Transplant Proc. 1998. PMID: 9723294 Review. No abstract available.

9

Conversion from Sandimmune to Neoral in stable liver graft recipients.

Pollard SG, Lodge JP. Pollard SG, et al. Transplant Proc. 1996 Aug;28(4):2244-6. Transplant Proc. 1996. PMID: 8769213 Clinical Trial. No abstract available.

10

Endovascular management of arterial conduit pseudoaneurysm after liver transplantation: a report of two cases.

Banga NR, Kessel DO, Patel JV, White SA, Pollard SG, Prasad KR, Toogood GJ. Banga NR, et al. Transplantation. 2005 Jun 27;79(12):1763-5. doi: 10.1097/01.tp.0000163287.14796.45. Transplantation. 2005. PMID: 15973183

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

560 results

Search Page

Filters